A clinical trial to study the effect of Hair4U 10% containing (minoxidil 10% plus Aminexil 1.5%)in treatment of male pattern of baldness
Phase 4
Completed
- Conditions
- Health Condition 1: null- Androgenetic Alopecia
- Registration Number
- CTRI/2011/06/001813
- Lead Sponsor
- Glenmark Pharmaceuticals Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 75
Inclusion Criteria
Subjects with androgenetic alopecia grade from II to IV.
Male subjects must be between 18-50years of age.
Subject must provide informed consent and comply with protocol.
Exclusion Criteria
Subjects not willing to discontinue all the treatments of androgenetic alopecia 2 weeks prior to enrollement in the study.
hypersensitivity o any of the ingredients.
subjects taking concomitant therapy that might interfere with the study results in investigators opinion.
subjects with dermatological disorder of scalp that miht interfere with study evaluation.
Study & Design
- Study Type
- PMS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in bald areaTimepoint: Reduction in bald area
- Secondary Outcome Measures
Name Time Method ILTimepoint: NI